Gene · 8767
Papers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nucleated red blood cell count as a novel predictive biomarker for acute kidney injury and prognosis in patients with acute pancreatitis: A retrospective cohort study. | PLoS One | 2025 | 40844988 | PubTator, text mining | PubMed |
| Prkci activates Jak2/Stat3 signaling to promote tumor angiogenesis: Short Name: Prkci in tumor angiogenesis. | Neoplasia | 2025 | 40840329 | PubTator, text mining | PubMed |
| Multi-function of adipose-derived stem cells on gut disorder: from bench to bedside. | Stem Cell Res Ther | 2025 | 40830985 | PubTator, text mining | PubMed |
| Resolving the field: a role for Nod2 in T cells. | J Immunol | 2025 | 40824708 | PubTator, text mining | PubMed |
| PGRP-S promotes hepatocellular carcinoma progression via MAPK/ERK pathway by interaction with TTC1. | Sci Rep | 2025 | 40760131 | PubTator, text mining | PubMed |
| Role of NRP1/HDAC4/CREB/RIPK1 Axis in SARS-CoV2 S1 Spike Subunit-Induced Neuronal Toxicity. | FASEB Bioadv | 2025 | 40746867 | PubTator, text mining | PubMed |
| In silico analysis of atrial fibrillation and hypertension mechanism of action secondary to ibrutinib/acalabrutinib in chronic lymphocytic leukemia. | Sci Rep | 2025 | 40744952 | PubTator, text mining | PubMed |
| Anti-Cryptosporidium efficacy of BKI-1708, an inhibitor of Cryptosporidium calcium-dependent protein kinase 1. | PLoS Negl Trop Dis | 2025 | 40737275 | PubTator, text mining | PubMed |
| CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury. | Acta Pharm Sin B | 2025 | 40698146 | PubTator, text mining | PubMed |
| A transformer-based strategy to develop RP20 as a potent RIPK2 inhibitor for acetaminophen-induced acute liver injury. | Acta Pharm Sin B | 2025 | 40698128 | PubTator, text mining | PubMed |
| Identification of hub six interferon alpha response genes and immune cell infiltration characteristics in low-grade glioma. | Sci Rep | 2025 | 40651996 | PubTator, text mining | PubMed |
| Development of Thieno[3,2-d]pyrimidine derivatives as potent RIPK2 inhibitors with Prominent In vitro and In vivo anti-inflammatory efficacy. | Eur J Med Chem | 2025 | 40639288 | PubTator, text mining | PubMed |
| Juanbi Qianggu Formula inhibits fibroblast-like synovicytes activation via repressing LncRNA ITSN1-2 to promote RIP2 K48 ubiquitination. | Chin Med | 2025 | 40629453 | PubTator, text mining | PubMed |
| Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy. | Proc Natl Acad Sci U S A | 2025 | 40623177 | PubTator, text mining | PubMed |
| Unraveling chain specific ubiquitination in cells using tandem ubiquitin binding entities. | Sci Rep | 2025 | 40595035 | PubTator, text mining | PubMed |
| The Role of Pattern Recognition Receptors in Epigenetic and Metabolic Reprogramming: Insights into Trained Immunity. | J Inflamm Res | 2025 | 40535352 | PubTator, text mining | PubMed |
| Correction to: Joint NOD2/RIPK2 Signaling Regulates IL-17 Axis and Contributes to the Development of Experimental Arthritis. | J Immunol | 2025 | 40514038 | PubTator, text mining | PubMed |
| Combining xQTL and genome-wide association studies from ethnically diverse populations improves druggable gene discovery. | Res Sq | 2025 | 40502754 | PubTator, text mining | PubMed |
| Current advances on RIPK2 and its inhibitors in pathological processes: a comprehensive review. | Front Mol Neurosci | 2025 | 40406369 | PubTator, text mining | PubMed |
| RIP2/NF-κB/PD-L1 signaling pathway is involved in temozolomide resistance by inducing autophagy in glioblastoma cells. | Transl Oncol | 2025 | 40403475 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8767/papers?page=4